The data is there. So why aren’t we using it?
Reflections from HLTH Europe 2026, where I [...]
Improving market access of medicines in the UK – Our view in 2024
Addressing access and adoption of medicines in the UK [...]
Emerging trends in life sciences markets: The UK as an Innovation Hub
The global life sciences industry is undergoing a period [...]
The Challenge and Promise of UK Life Sciences
The promise of life sciences innovation is exciting. Disease-modifying [...]
What will it take to transform Alzheimer’s with the new wave of medicines?
The first wave of effective Disease Modifying Therapies (DMT) [...]
The Approach to Obesity Management in the UK: A Review, Opportunities and Next Steps
With the advent of several first generation GLP-1 agonist [...]
